Pharmaceutical company Eli Lilly recently warned that some Medicare drug plans may charge more than the expected $50 monthly cap for certain weight-loss medications. The issue highlights the complexity of how new drug pricing policies interact with Medicare prescription drug coverage. While reforms aim to reduce costs for seniors, experts say the rollout may vary depending on how insurers structure their formularies.
